FIA
NVO

FNY Investment Advisers’s Novo Nordisk NVO Stock Holding History

FNY Investment Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-430
Closed -$21K – 999
2025
Q4 		$21K Buy
+430
New +$22K 0.01% 558
2022
Q4 		– Sell
-154
Closed -$7K – 675
2022
Q3 		$7K Buy
+154
New +$8.25K ﹤0.01% 429

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

FNY Investment Advisers's NVO Position: Q2 2026 in Review

FNY Investment Advisers reduced its Novo Nordisk (NVO) stake by 46% in Q2 2026, selling an estimated $42.5K and leaving 1,140 shares worth $54K. The position accounts for 0.02% of the portfolio, ranked #407.

FNY Investment Advisers first reported a position in NVO in Q3 2019 and has held it in 11 quarters since. The position peaked at $3.98M in Q3 2022. 1,041 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • FNY Investment Advisers held 1,140 shares of Novo Nordisk worth $54K as of Q2 2026.
  • FNY Investment Advisers sold 990 Novo Nordisk shares in Q2 2026, an estimated $42.5K.
  • Novo Nordisk made up 0.02% of FNY Investment Advisers's portfolio in Q2 2026, its #407 holding.
  • FNY Investment Advisers first reported a position in Novo Nordisk in Q3 2019 and has held it in 11 quarters since.
  • FNY Investment Advisers's Novo Nordisk position peaked at $3.98M in Q3 2022.
  • 1,041 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.